miRagen Therapeutics to Participate in Two Investor Conferences in May

26 Apr 2017 - Yahoo News
BOULDER, Colo., April 26, 2017-- Miragen Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of microRNA-targeted therapies, today announced that William ...
usx:mgen

---

miRagen Therapeutics to Present MRG-201 Data at the Society for Investigative Dermatology Annual Meeting

20 Apr 2017 - Yahoo News
BOULDER, Colo., April 20, 2017-- Miragen Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of microRNA-targeted therapies, announced today that interim ...
usx:mgen

---

4:15 pm Miragen Therapeutics reported recent clinical and financial highlights along with anticipated milestones for 2017

2 Apr 2017 - Yahoo News
4:15 pm Miragen Therapeutics reported recent clinical and financial highlights along with anticipated milestones for 2017
usx:mgen

---

MIRAGEN THERAPEUTICS, INC. Files SEC form 8-K/A, Financial Statements and Exhibits

31 Mar 2017 - Yahoo News
MIRAGEN THERAPEUTICS, INC. Files SEC form 8-K/A, Financial Statements and Exhibits
usx:mgen

---

miRagen Therapeutics Provides Corporate Update

31 Mar 2017 - Yahoo News
[GlobeNewswire] - BOULDER, Colo., March 31, 2017-- miRagen Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of microRNA-targeted therapies, today reported recent clinical ...
usx:mgen

---

miRagen Therapeutics Receives Orphan-Drug Designation for MRG-106 for the Treatment of Mycosis Fungoides

31 Mar 2017 - Yahoo News
[GlobeNewswire] - BOULDER, Colo., March 31, 2017-- miRagen Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of microRNA-targeted therapies, today announced that the ...
usx:mgen

---

MIRAGEN THERAPEUTICS, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Change in Directors or

30 Mar 2017 - Yahoo News
MIRAGEN THERAPEUTICS, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Change in Directors or
usx:mgen

---

MIRAGEN THERAPEUTICS, INC. Financials

30 Mar 2017 - Yahoo News
MIRAGEN THERAPEUTICS, INC. Financials
usx:mgen

---

miRagen Therapeutics to Present at the Needham and Company 16th Annual Healthcare Conference

28 Mar 2017 - Yahoo News
[GlobeNewswire] - BOULDER, Colo., March 28, 2017-- Miragen Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of microRNA-targeted therapies, today announced that William ...
usx:mgen

---